Vibroacoustic Products Listed as Class I Medical Devices; Red Light Therapy Products Listed as Class II Medical Devices ...
Stockholm, Sweden, February 16, 2026. Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm: EGTX), today announced that its Japanese partner Fujimoto Pharmaceuticals, who has an ...
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results